Evoke Pharma (EVOK) Tops Q4 EPS by 8c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.37), $0.08 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance